ロード中...
Novel HDL-directed pharmacotherapeutic strategies
The burden of atherothrombotic cardiovascular disease remains high despite currently available optimum medical therapy. To address this substantial residual risk, the development of novel therapies that attempt to harness the atheroprotective functions of HDL is a major goal. These functions include...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3315102/ https://ncbi.nlm.nih.gov/pubmed/21243009 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrcardio.2010.200 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|